Results 41 to 50 of about 51,898 (168)
Background: Type 2 diabetes (T2DM) affects over 500 million people worldwide, and over 50% of this group experience the most common complication, diabetic peripheral neuropathy (DPN). The presence of advanced glycation end-products (AGEs) has been linked
Indumathi Singh +5 more
doaj +1 more source
Aims/Introduction Advanced glycation end‐products (AGEs), which are a major cause of diabetic vascular complications, accumulate in various tissues under chronic hyperglycemic conditions, as well as with aging in patients with diabetes.
Hiroyasu Mori +14 more
doaj +1 more source
Background Chronic deposits of advanced glycation end products produced by enzymatic glycation have been suggested as predictors of atherosclerotic‐related disorders.
Ivan Cavero‐Redondo +7 more
doaj +1 more source
The interaction of Advanced Glycation End products (AGEs) and their specific receptor, Receptor for Advanced Glycation End products (RAGE) play an important role in diabetes and vascular complications.
Claudia Borsa +4 more
doaj +1 more source
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. [PDF]
Chih‐Wei Yang +5 more
openalex +1 more source
Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex [PDF]
Helen Vlassara +6 more
openalex +1 more source
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin [PDF]
Osamu Hori +12 more
openalex +1 more source
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding [PDF]
Sherif Youssef +5 more
openalex +1 more source
Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells [PDF]
Jau‐Shyang Huang +6 more
openalex +1 more source

